Elektrofi
Bernice Yeung is an experienced professional in analytical development with a robust background in the biopharmaceutical industry. Currently serving as Executive Director of Analytical Development at Elektrofi since November 2023, Yeung's previous roles include Senior Director and Head of Analytical Development at Biogen, as well as Global Head of Characterization at Shire. Throughout a career spanning over two decades, Yeung has held various leadership positions focusing on the characterization and analytical comparability of biologics, formulation development, and in-depth product characterization using advanced analytical techniques. Yeung's educational background includes a PhD in Analytical Chemistry from Northeastern University and a Bachelor's Degree in Chemistry from the University of Delaware.
This person is not in any teams
This person is not in any offices
Elektrofi
1 followers
Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company’s founding team of MIT engineers and scientists are shaping the future of biologics delivery.